TAK logo

TAK Financing Cash Flow

Latest reported-¥462.27B JPY
TAK TTM Cash from Financing · JPY (-¥144.82B → -¥462.27B)
High-resolution chart · PNG

TAK financing cash flow history

Trailing twelve months (TTM) · JPY. Each value covers four complete reported quarters.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Financing Cash Flow — Trailing twelve months (TTM) (JPY)
Period endingFinancing Cash Flow (JPY)
-462,268,000,000
-496,820,000,000
-721,120,000,000
-1,184,642,000,000
-1,282,706,000,000
-751,425,000,000
-507,856,000,000
50,353,000,000
19,743,000,000
-354,416,000,000
-302,793,000,000
-639,988,000,000
-551,209,000,000
-709,148,000,000
-946,348,000,000
-679,453,000,000
-874,944,000,000
-1,070,265,000,000
-1,196,537,000,000
-1,328,549,000,000
-1,306,627,000,000
-1,088,354,000,000
-862,213,000,000
-611,753,000,000
-1,020,278,000,000
-1,005,213,000,000
672,982,000,000
2,231,741,000,000
2,850,701,000,000
2,946,237,000,000
1,262,009,000,000
-315,270,000,000
-320,561,000,000
-326,226,000,000
82,188,000,000
83,680,000,000
89,632,000,000
289,896,000,000
69,473,000,000
71,539,000,000
74,166,000,000
-124,839,000,000
-294,695,000,000
-293,171,000,000
-308,308,000,000
-300,998,000,000
-177,067,000,000
-177,803,000,000
86,113,000,000
101,441,000,000
109,339,000,000
173,125,000,000
-63,932,000,000
-9,651,000,000
-73,482,000,000
-82,819,000,000
-146,544,000,000
-148,014,000,000
-147,052,000,000
-146,523,000,000
-148,046,000,000
-144,815,000,000
-268,953,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.